Dataset Information


Efficacy of vortioxetine on the physical symptoms of major depressive disorder.

ABSTRACT: BACKGROUND:Efficacy has been proven for vortioxetine in short-term and long-term treatment of major depressive disorder (MDD), with broad beneficial effects on emotional, physical and cognitive symptoms. Limited specific data on the effects of vortioxetine on depression-related physical symptoms have been published. METHODS:A meta-analysis was carried out of five short-term multinational, double-blind, placebo-controlled studies. These studies were conducted in a total of 2105 adult MDD outpatients (18-75 years) with a major depressive episode of ?3 months' duration. Only patients treated with a dose of 5 or 10 mg vortioxetine (therapeutic doses) or placebo were included in this analysis. Efficacy assessment of vortioxetine on the physical symptoms of depression included all items of the Hamilton Depression Scale (HAM-D) assessing physical symptoms, and all somatic items in the Hamilton Anxiety Scale (HAM-A). A subgroup analysis in MDD patients with coexisting anxiety symptoms (i.e. those with a HAM-A ?20 at baseline) was also performed. RESULTS:A significant improvement ( p<0.05) of vortioxetine versus placebo was observed on all HAM-D items measuring physical symptoms, except for the somatic gastrointestinal symptoms and loss of weight items. Significant effects were also observed on the HAM-A somatic items: general somatic symptoms, gastrointestinal symptoms, and autonomic symptoms. In patients with a high baseline level of anxiety, a significant effect of vortioxetine was also observed on the physical symptoms of depression. CONCLUSIONS:These analyses indicate that patients with MDD, including those with a high level of anxiety symptoms, have significant improvements in MDD-associated physical symptoms when treated with vortioxetine.

PROVIDER: S-EPMC6380624 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC8710584 | BioStudies
| S-EPMC5322850 | BioStudies
| S-EPMC7027855 | BioStudies
2017-01-01 | S-EPMC5552140 | BioStudies
| S-EPMC9185761 | BioStudies
| S-EPMC8115127 | BioStudies
| S-EPMC8364372 | BioStudies
| S-EPMC4910384 | BioStudies
2015-01-01 | S-EPMC4409435 | BioStudies
| S-EPMC6097511 | BioStudies